Download video

Dr. Luke Nordquist on the Impact of Additional Doses of Radium-223 in mCRPC

123 views

OncLive

8 years ago

Dr. Luke Nordquist on the Impact of Additional Doses of Radium-223 in mCRPC

Dr. Luke Nordquist on the Impact of Additional Doses of Radium-223 in mCRPC

Dr. Luke Nordquist on the Impact of Additional Doses of Radium-223 in mCRPC
0:59
Dr. Luke Nordquist on the Impact of Additional Doses of Radium-223 in mCRPC
by OncLive
Dr. Luke Nordquist on Radium-223 Retreatment
1:07
Dr. Luke Nordquist on Radium-223 Retreatment
by OncLive
Dr. Luke Nordquist on Who Should Receive Radium-223
0:49
Dr. Luke Nordquist on Who Should Receive Radium-223
by OncLive
An Overview of the ALSYMPCA Study in Metastatic Prostate Cancer
2:09
An Overview of the ALSYMPCA Study in Metastatic Prostate Cancer
by Targeted Oncology
Dr. Kelly on Identifying Optimal Dose of Radium-223 and Niraparib in mCRPC
1:19
Dr. Kelly on Identifying Optimal Dose of Radium-223 and Niraparib in mCRPC
by OncLive
PEACE-3 Study ESMO 2024 - Combining Enzalutamide + Radium-223 in mCRPC
2:57
PEACE-3 Study ESMO 2024 - Combining Enzalutamide + Radium-223 in mCRPC
by Oncology Brothers Clips
Dr. Saad on Patients With mCRPC Eligible for 6-Doses of Radium-223
1:51
Dr. Saad on Patients With mCRPC Eligible for 6-Doses of Radium-223
by OncLive
Dr. Kelly on Efficacy of Radium-223 Dichloride and Niraparib in Patients With mCRPC
1:40
Dr. Kelly on Efficacy of Radium-223 Dichloride and Niraparib in Patients With mCRPC
by OncLive
part 3 Is it all same disease
19:12
part 3 Is it all same disease
by Peter Rogers MD
2024 Update | Lu-177 (Pluvicto), Actinium \& New #ProstateCancer AntiBody | Dr. Nat Lenzo #AlexScholz
57:58
2024 Update | Lu-177 (Pluvicto), Actinium \& New #ProstateCancer AntiBody | Dr. Nat Lenzo #AlexScholz
by Prostate Cancer Research Institute
Functional Imaging and Recurring Prostate Cancer
19:04
Functional Imaging and Recurring Prostate Cancer
by University of California Television (UCTV)
Dr. Sartor on Mechanism of Action and Safety of Radium-223 in mCRPC
1:24
Dr. Sartor on Mechanism of Action and Safety of Radium-223 in mCRPC
by OncLive
Dr. Oliver Sartor on Doubling the Dosage of Radium-223 in Patients With CRPC
1:41
Dr. Oliver Sartor on Doubling the Dosage of Radium-223 in Patients With CRPC
by Targeted Oncology
Benefits and Limitations of Radium-223 in mCRPC
2:06
Benefits and Limitations of Radium-223 in mCRPC
by Targeted Oncology
Dr. Petrylak Discusses the Isotope Radium-223
0:57
Dr. Petrylak Discusses the Isotope Radium-223
by OncLive
Dr. Saad Discusses the Benefit of Radium-223 in Patients with mCRPC
1:37
Dr. Saad Discusses the Benefit of Radium-223 in Patients with mCRPC
by Targeted Oncology
Dr. Morris on Novel Approaches With Radium-223 in mCRPC
1:05
Dr. Morris on Novel Approaches With Radium-223 in mCRPC
by OncLive
RAVENS: Analyzing Radium-223 vs SABR for Oligometastatic HSPC
7:24
RAVENS: Analyzing Radium-223 vs SABR for Oligometastatic HSPC
by GU Oncology Now
Dr. O’Sullivan Discusses Moving Radium-223 Up in Treatment Sequence for mCRPC
1:08
Dr. O’Sullivan Discusses Moving Radium-223 Up in Treatment Sequence for mCRPC
by Targeted Oncology
Dr. Kelly on the Rationale for Combining Radium-223 and Niraparib in mCRPC
1:01
Dr. Kelly on the Rationale for Combining Radium-223 and Niraparib in mCRPC
by OncLive
Dr. Finkelstein Summarizes the Development of Radium-223
1:08
Dr. Finkelstein Summarizes the Development of Radium-223
by OncLive
Radium 223: Counseling Patients With mCRPC
10:45
Radium 223: Counseling Patients With mCRPC
by Targeted Oncology
Phase1b Trial Investigates Atezolizumab and Radium-223 in mCRPC
2:08
Phase1b Trial Investigates Atezolizumab and Radium-223 in mCRPC
by Targeted Oncology